| 3D | three dimensional; |
| AO | adverse outcome; |
| BSA | bovine serum albumin; |
| CAS | chemical abstracts service; |
| CNS | central nervous system; |
| Ctrl | control; |
| D | day; |
| DNT | developmental neurotoxicity; |
| EC | effective concentration; |
| ER | endoplasmic reticulum; |
| FBS | fetal bovine serum; |
| HE | Hematoxylin-Eosin; |
| HTS | high-throughput screening; |
| hiPSC | human induced pluripotent stem cell; |
| ICC | immunocytochemistry; |
| iPSC | induced pluripotent stem cell; |
| NA | numeric aperture; |
| NAM | new approach method; |
| NEAA | non-essential amino acids; |
| NIM | neural induction media; |
| NMM | neural maintenance media; |
| NPC | neural progenitor cell; |
| NSC | neural stem cell; |
| O/N | overnight; |
| PBMC | peripheral blood mononuclear cells; |
| PBS | phosphate buffer saline; |
| PCR | polymerase chain reaction; |
| PFA | Paraformaldehyde; |
| POL/L | Poly-l-ornithine and Laminin; |
| PSC | pluripotent stem cell; |
| RT | room temperature; |
| rTdT | recombinant terminal deoxynucleotidyl transferase; |
| RT-PCR | reverse transcription polymerase chain reaction; |
| TEM | transmission electron microscopy; |
| TUNEL | terminal deoxynucleotidyl transferase dUTP nick end labeling. |